# Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients

> **NCT02764697** · PHASE4 · COMPLETED · sponsor: **Tampa Bay Uveitis Center, LLC** · enrollment: 6 (actual)

## Conditions studied

- Uveitis
- Anterior Uveitis
- Intermediate Uveitis
- Posterior Uveitis
- Scleritis
- Clinically Significant Macular Edema

## Interventions

- **DRUG:** H.P. ACTHAR SUBCUTANEOUS GEL INJECTION

## Key facts

- **NCT ID:** NCT02764697
- **Lead sponsor:** Tampa Bay Uveitis Center, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-30
- **Primary completion:** 2016-12-07
- **Final completion:** 2016-12-20
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02764697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02764697, "Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02764697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*